Access to anti-retroviral drugs, male in Argentina

Argentina: Access to anti-retroviral drugs, male was 74.0% in 2024. ▲ Rising

Latest (2024)
74.0%
Change on year
up 2.8%
World rank
58th
of 141 countries
All-time high
74.0%
in 2024
All-time low
17.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Argentina, 2000–2024

204060802000201220242000: 17 %2001: 21 %2002: 24 %2003: 26 %2004: 29 %2005: 31 %2006: 32 %2007: 36 %2008: 38 %2009: 41 %2010: 44 %2011: 47 %2012: 49 %2013: 52 %2014: 55 %2015: 58 %2016: 61 %2017: 63 %2018: 66 %2019: 68 %2020: 70 %2021: 72 %2022: 70 %2023: 72 %2024: 74 %

Source: UNAIDS estimates. Measured in %.

Analysis

Argentina recorded 74.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.

That represents a change of up 2.8% on the previous year and up 34.5% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Argentina peaked at 74.0% in 2024 and was at its lowest, 17.0%, in 2000.

That places Argentina 58th out of 141 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Argentina, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Argentina, 2000 to 2024.
Year % Change
2000 17.0%
2001 21.0% +23.5%
2002 24.0% +14.3%
2003 26.0% +8.3%
2004 29.0% +11.5%
2005 31.0% +6.9%
2006 32.0% +3.2%
2007 36.0% +12.5%
2008 38.0% +5.6%
2009 41.0% +7.9%
2010 44.0% +7.3%
2011 47.0% +6.8%
2012 49.0% +4.3%
2013 52.0% +6.1%
2014 55.0% +5.8%
2015 58.0% +5.5%
2016 61.0% +5.2%
2017 63.0% +3.3%
2018 66.0% +4.8%
2019 68.0% +3.0%
2020 70.0% +2.9%
2021 72.0% +2.9%
2022 70.0% -2.8%
2023 72.0% +2.9%
2024 74.0% +2.8%

Averages by decade

DecadeAverage LowestHighest Years
2000s 29.5% 17.0% 41.0% 10
2010s 56.3% 44.0% 68.0% 10
2020s 71.6% 70.0% 74.0% 5

Countries ranked near Argentina

  1. 55 Congo, Democratic Republic of the 75.0% compare
  2. 55 South Africa 75.0% compare
  3. 55 Viet Nam 75.0% compare
  4. 58 Bahamas 74.0% compare
  5. 58 Gabon 74.0% compare
  6. 58 Malta 74.0% compare

See the full ranking of 160 places →

More gender data for Argentina

All data for Argentina →

Frequently asked questions

What is access to anti-retroviral drugs, male in Argentina?
Access to anti-retroviral drugs, male in Argentina was 74.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Argentina?
The highest recorded value was 74.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Argentina?
The lowest recorded value was 17.0% in 2000.
How does Argentina rank for access to anti-retroviral drugs, male?
Argentina ranks 58th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Argentina?
Over the last ten years it is up 34.5%. The long-run trend across the full record is rising.
Where does this Argentina data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Argentina. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/argentina/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/argentina/">Access to anti-retroviral drugs, male in Argentina</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.